Brief: Helix Biopharma Reports Q3 Shr Loss C$0.02
12/06/2018 22:38
June 12 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP ANNOUNCES FISCAL THIRD QUARTER 2018
RESULTS
* Q3 LOSS PER SHARE C$0.02
Source text: [https://reut.rs/2JNbYfu]
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020